HHS expands availability of monkeypox vaccine to more than 1.1 million doses

Aug. 1, 2022
HHS monkeypox update.

The U.S. Department of Health and Human Services (HHS) announced plans to allocate an additional 786,000 doses of JYNNEOS vaccine, dramatically increasing the supply of monkeypox vaccine doses to states and jurisdictions.

The additional vaccine allocation adds to the more than 340,000 doses of JYNNEOS vaccine that have already been delivered to jurisdictions. JYNNEOS vaccine is manufactured by Bavarian Nordic and approved by the Food and Drug Administration to prevent smallpox and monkeypox.

The plan for allocating the doses takes into account two key factors: the total population of at-risk people and the number of new cases in each jurisdiction. The strategy ensures that jurisdictions have the doses needed to complete the second dose of this two-dose vaccine regimen for those who have been vaccinated over the past month. Beginning Friday, July 29, states and jurisdictions can order additional vaccine doses through HHS.

HHS release